Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer

Objective: Our study aimed to investigate the expression level and clinical significance of serum and exhaled breath condensate miR-186 and IL-1β in non-small cell lung cancer patients. Methods: The serum and exhaled breath condensate specimens of 62 non-small cell lung cancer patients and 60 health...

Full description

Bibliographic Details
Main Authors: Haiqin Xie MSc, Jinliang Chen PhD, Xuedong Lv MBBS, Lu Zhang MSc, Jinnan Wu MSc, Xin Ge MSc, Qichang Yang MBBS, Dongmei Zhang PhD, Jianrong Chen MBBS
Format: Article
Language:English
Published: SAGE Publishing 2020-08-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/1533033820947490
id doaj-cbdb783674c549e2bd541661e2f905a0
record_format Article
spelling doaj-cbdb783674c549e2bd541661e2f905a02020-11-25T03:52:52ZengSAGE PublishingTechnology in Cancer Research & Treatment1533-03382020-08-011910.1177/1533033820947490Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung CancerHaiqin Xie MSc0Jinliang Chen PhD1Xuedong Lv MBBS2Lu Zhang MSc3Jinnan Wu MSc4Xin Ge MSc5Qichang Yang MBBS6Dongmei Zhang PhD7Jianrong Chen MBBS8 Department of Respiratory Medicine, Affiliated Hospital 2 of Nantong University, Nantong, China Department of Respiratory Medicine, Affiliated Hospital 2 of Nantong University, Nantong, China Department of Respiratory Medicine, Affiliated Hospital 2 of Nantong University, Nantong, China Department of Respiratory Medicine, Affiliated Hospital 2 of Nantong University, Nantong, China Department of Respiratory Medicine, Affiliated Hospital 2 of Nantong University, Nantong, China Medical Research Center, Affiliated Hospital 2 of Nantong University, Nantong, China Department of Pathology, Affiliated Hospital 2 of Nantong University, Nantong, China Medical Research Center, Affiliated Hospital 2 of Nantong University, Nantong, China Medical Research Center, Affiliated Hospital 2 of Nantong University, Nantong, ChinaObjective: Our study aimed to investigate the expression level and clinical significance of serum and exhaled breath condensate miR-186 and IL-1β in non-small cell lung cancer patients. Methods: The serum and exhaled breath condensate specimens of 62 non-small cell lung cancer patients and 60 healthy controls were collected to detect miR-186 expression levels by real-time fluorescent quantitative PCR. Enzyme linked immunosorbent assay was applied to examine IL-1β concentration. Statistical analyses were used to evaluate the correlation between miR-186 and IL-1β in serum and clinicopathological features, traditional serum tumor markers, and inflammatory markers. The diagnostic efficacy of miR-186 and IL-1β for non-small cell lung cancer was evaluated by receiver operating characteristic curve analysis. The correlation between miR-186 and IL-1β was determined. Results: ① The relative expression level of miR-186 was greatly reduced in the serum and EBC of patients with non-small cell lung cancer, and the miR-186 expression level was reduced in different TNM stages of non-small cell lung cancer, from the early to later stages. ② The IL-1β concentration in serum and exhaled breath condensate of patients with non-small cell lung cancer was increased. ③ Serum miR-186 and IL-1β levels were closely related to lymph node metastasis, and the low expression of serum miR-186 and the high concentration of IL-1β were associated with higher serum carcinoembryonic antigen, C-reactive protein, and erythrocyte sedimentation rate levels. ④ ROC curve analysis showed that exhaled breath condensate miR-186 had higher area under the curve than serum miR-186, and the combined detection showed higher diagnostic efficacy than the separate detection. In addition, the combined detection of IL-1β and miR-186 has a larger AUC than the separate detection of both. ⑤ The correlation between serum miR-186 and IL-1β was negative. Conclusion: miR-186 and IL-1β are expected to be potential diagnostic biomarkers for non-small cell lung cancer.https://doi.org/10.1177/1533033820947490
collection DOAJ
language English
format Article
sources DOAJ
author Haiqin Xie MSc
Jinliang Chen PhD
Xuedong Lv MBBS
Lu Zhang MSc
Jinnan Wu MSc
Xin Ge MSc
Qichang Yang MBBS
Dongmei Zhang PhD
Jianrong Chen MBBS
spellingShingle Haiqin Xie MSc
Jinliang Chen PhD
Xuedong Lv MBBS
Lu Zhang MSc
Jinnan Wu MSc
Xin Ge MSc
Qichang Yang MBBS
Dongmei Zhang PhD
Jianrong Chen MBBS
Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer
Technology in Cancer Research & Treatment
author_facet Haiqin Xie MSc
Jinliang Chen PhD
Xuedong Lv MBBS
Lu Zhang MSc
Jinnan Wu MSc
Xin Ge MSc
Qichang Yang MBBS
Dongmei Zhang PhD
Jianrong Chen MBBS
author_sort Haiqin Xie MSc
title Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer
title_short Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer
title_full Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer
title_fullStr Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer
title_full_unstemmed Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer
title_sort clinical value of serum and exhaled breath condensate mir-186 and il-1β levels in non-small cell lung cancer
publisher SAGE Publishing
series Technology in Cancer Research & Treatment
issn 1533-0338
publishDate 2020-08-01
description Objective: Our study aimed to investigate the expression level and clinical significance of serum and exhaled breath condensate miR-186 and IL-1β in non-small cell lung cancer patients. Methods: The serum and exhaled breath condensate specimens of 62 non-small cell lung cancer patients and 60 healthy controls were collected to detect miR-186 expression levels by real-time fluorescent quantitative PCR. Enzyme linked immunosorbent assay was applied to examine IL-1β concentration. Statistical analyses were used to evaluate the correlation between miR-186 and IL-1β in serum and clinicopathological features, traditional serum tumor markers, and inflammatory markers. The diagnostic efficacy of miR-186 and IL-1β for non-small cell lung cancer was evaluated by receiver operating characteristic curve analysis. The correlation between miR-186 and IL-1β was determined. Results: ① The relative expression level of miR-186 was greatly reduced in the serum and EBC of patients with non-small cell lung cancer, and the miR-186 expression level was reduced in different TNM stages of non-small cell lung cancer, from the early to later stages. ② The IL-1β concentration in serum and exhaled breath condensate of patients with non-small cell lung cancer was increased. ③ Serum miR-186 and IL-1β levels were closely related to lymph node metastasis, and the low expression of serum miR-186 and the high concentration of IL-1β were associated with higher serum carcinoembryonic antigen, C-reactive protein, and erythrocyte sedimentation rate levels. ④ ROC curve analysis showed that exhaled breath condensate miR-186 had higher area under the curve than serum miR-186, and the combined detection showed higher diagnostic efficacy than the separate detection. In addition, the combined detection of IL-1β and miR-186 has a larger AUC than the separate detection of both. ⑤ The correlation between serum miR-186 and IL-1β was negative. Conclusion: miR-186 and IL-1β are expected to be potential diagnostic biomarkers for non-small cell lung cancer.
url https://doi.org/10.1177/1533033820947490
work_keys_str_mv AT haiqinxiemsc clinicalvalueofserumandexhaledbreathcondensatemir186andil1blevelsinnonsmallcelllungcancer
AT jinliangchenphd clinicalvalueofserumandexhaledbreathcondensatemir186andil1blevelsinnonsmallcelllungcancer
AT xuedonglvmbbs clinicalvalueofserumandexhaledbreathcondensatemir186andil1blevelsinnonsmallcelllungcancer
AT luzhangmsc clinicalvalueofserumandexhaledbreathcondensatemir186andil1blevelsinnonsmallcelllungcancer
AT jinnanwumsc clinicalvalueofserumandexhaledbreathcondensatemir186andil1blevelsinnonsmallcelllungcancer
AT xingemsc clinicalvalueofserumandexhaledbreathcondensatemir186andil1blevelsinnonsmallcelllungcancer
AT qichangyangmbbs clinicalvalueofserumandexhaledbreathcondensatemir186andil1blevelsinnonsmallcelllungcancer
AT dongmeizhangphd clinicalvalueofserumandexhaledbreathcondensatemir186andil1blevelsinnonsmallcelllungcancer
AT jianrongchenmbbs clinicalvalueofserumandexhaledbreathcondensatemir186andil1blevelsinnonsmallcelllungcancer
_version_ 1724480460036243456